{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:16:26Z","timestamp":1791303386127,"version":"4.1.0"},"reference-count":125,"publisher":"Frontline Medical Communications, Inc.","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.sder.2011.08.001","type":"journal-article","created":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T00:01:58Z","timestamp":1322956918000},"page":"199-209","source":"Crossref","is-referenced-by-count":104,"title":["Photodynamic Therapy: Current Evidence and Applications in Dermatology"],"prefix":"10.12788","volume":"30","author":[{"given":"Yoojin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elma D.","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2011.08.001_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1562\/0031-8655(2001)074<0656:THOPAP>2.0.CO;2","article-title":"The history of photodetection and photodynamic therapy","volume":"74","author":"Ackroyd","year":"2001","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib2","first-page":"S8","article-title":"Photodynamic therapy in dermatology: History and horizons","volume":"3","author":"Taub","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0006-291X(05)81017-4","article-title":"Evidence for the involvement of singlet oxygen in the photodestruction by chloroaluminum phthalocyanine tetrasulfonate","volume":"173","author":"Agarwal","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sder.2011.08.001_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1751-1097.1992.tb04222.x","article-title":"How does photodynamic therapy work?","volume":"55","author":"Henderson","year":"1992","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1011-1344(96)07291-0","article-title":"An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo","volume":"35","author":"Webber","year":"1996","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.sder.2011.08.001_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1751-1097.1993.tb04969.x","article-title":"Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: Electron microscopic, histopathologic and biochemical evidence","volume":"58","author":"Zaidi","year":"1993","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib7","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2307\/3579816","article-title":"The photobiology of photodynamic therapy: Cellular targets and mechanisms","volume":"150","author":"Oleinick","year":"1998","journal-title":"Radiat Res"},{"key":"10.1016\/j.sder.2011.08.001_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.sder.2011.08.001_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/lsm.20334","article-title":"Initiation of apoptosis and autophagy by photodynamic therapy","volume":"38","author":"Kessel","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.sder.2011.08.001_bib10","first-page":"5993","article-title":"Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells","volume":"51","author":"Agarwal","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.sder.2011.08.001_bib11","doi-asserted-by":"crossref","first-page":"47379","DOI":"10.1074\/jbc.M107678200","article-title":"Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells: Reactive oxygen species and mitochondrial inner membrane permeabilization","volume":"276","author":"Lam","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sder.2011.08.001_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10863-006-9064-8","article-title":"Mitochondria are targets of photodynamic therapy","volume":"39","author":"Hilf","year":"2007","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.sder.2011.08.001_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ijc.2910560214","article-title":"Changes in perfusion of mouse tumours after photodynamic therapy","volume":"56","author":"van Geel","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.sder.2011.08.001_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1751-1097.1995.tb09150.x","article-title":"Sites of photodamage in vivo and in vitro by a cationic porphyrin","volume":"62","author":"Kessel","year":"1995","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/1011-1344(90)85083-9","article-title":"Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience","volume":"6","author":"Kennedy","year":"1990","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.sder.2011.08.001_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/1011-1344(92)85108-7","article-title":"Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy","volume":"14","author":"Kennedy","year":"1992","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.sder.2011.08.001_bib17","first-page":"218","article-title":"Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester","volume":"68","author":"Fritsch","year":"1998","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1751-1097.1993.tb02282.x","article-title":"New phthalocyanine photosensitizers for photodynamic therapy","volume":"57","author":"Oleinick","year":"1993","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.taap.2007.01.025","article-title":"Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies","volume":"224","author":"Miller","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.sder.2011.08.001_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/lsm.20984","article-title":"Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: Results of a phase 1 clinical trial","volume":"42","author":"Baron","year":"2010","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.sder.2011.08.001_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease","volume":"42","author":"Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.08.001_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/1076-0512(95)99396-3","article-title":"Solar keratosis: An evolving squamous cell carcinoma\u2014Benign or malignant?","volume":"21","author":"Hurwitz","year":"1995","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2011.08.001_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mjd.2000.103343","article-title":"Clinical presentation of AK and squamous cell carcinoma","volume":"42","author":"Moy","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1067\/mjd.2000.103338","article-title":"The treatment of AK","volume":"42","author":"Dinehart","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus\u2014International Society for Photodynamic Therapy in Dermatology, 2005","volume":"56","author":"Braathen","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.sder.2011.08.001_bib27","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1080\/095466302317414663","article-title":"Levulan: The first approved topical photosensitizer for the treatment of actinic keratosis","volume":"13","author":"Jeffes","year":"2002","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.sder.2011.08.001_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2001.114288","article-title":"Photodynamic therapy of AK with topical aminolevulinic acid hydrochloride and fluorescent blue light","volume":"45","author":"Jeffes","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.140.1.41","article-title":"Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple AK of the face and scalp: Investigator-blinded, phase 3, multicenter trials","volume":"140","author":"Piacquadio","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0190-9622(99)70114-3","article-title":"A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of AK","volume":"41","author":"Kurwa","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib31","first-page":"629","article-title":"Short incubation PDT versus 5-FU in treating AK","volume":"2","author":"Smith","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib32","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1365-2133.2006.07520.x","article-title":"Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic AK of the face and scalp: Phase IV multicentre clinical trial with 12-month follow up","volume":"155","author":"Tschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00015550510032887","article-title":"A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp","volume":"85","author":"Tarstedt","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2011.08.001_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1067\/mjd.2003.49","article-title":"Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial","volume":"48","author":"Pariser","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2008.05.031","article-title":"Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple AK: A randomized, double-blind, placebo-controlled study","volume":"59","author":"Pariser","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1067\/mjd.2002.119649","article-title":"Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study","volume":"47","author":"Szeimies","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09546630310012118","article-title":"A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: A prospective, randomized study","volume":"14","author":"Freeman","year":"2003","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.sder.2011.08.001_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2133.2007.07946.x","article-title":"Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis","volume":"157","author":"Moloney","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3322\/canjclin.40.4.237","article-title":"Bowen's disease","volume":"40","author":"Lee","year":"1990","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.sder.2011.08.001_bib40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2133.1994.tb03407.x","article-title":"Body site distribution of Bowen's disease","volume":"130","author":"Cox","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib41","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.1986.01660220042010","article-title":"Carcinoma arising in Bowen's disease","volume":"122","author":"Kao","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib42","series-title":"Cancer Dermatology","article-title":"Precancerous lesions","author":"Maize","year":"1979"},{"key":"10.1016\/j.sder.2011.08.001_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.2007.00317.x","article-title":"Therapeutic options for Bowen's disease","volume":"48","author":"Moreno","year":"2007","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2006.07610.x","article-title":"Guidelines for management of Bowen's disease: 2006 update","volume":"156","author":"Cox","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2133.1996.tb03887.x","article-title":"Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease","volume":"135","author":"Morton","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.TP.0000107284.04969.5C","article-title":"Topical photodynamic therapy in the treatment of AK and Bowen's disease in transplant recipients","volume":"77","author":"Dragieva","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.sder.2011.08.001_bib48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archderm.142.6.729","article-title":"Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial","volume":"142","author":"Morton","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post-transplant premalignant skin disease: A randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-0960.1998.tb01250.x","article-title":"Treatment of cutaneous Bowen's disease with particular emphasis on the problem of lower leg lesions","volume":"39","author":"Ball","year":"1998","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib51","first-page":"319","article-title":"Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma","volume":"137","author":"Morton","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-2133.1997.tb03944.x","article-title":"Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy","volume":"136","author":"Stables","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0738-081X(95)00061-J","article-title":"Historical aspects of nonmelanoma skin cancer","volume":"13","author":"Jackson","year":"1995","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R","article-title":"Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA: New Hampshire Skin Cancer Study Group","volume":"81","author":"Karagas","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.sder.2011.08.001_bib55","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1524-4725.1986.tb01993.x","article-title":"Trends in the presentation and treatment of basal cell carcinomas","volume":"12","author":"Roenigk","year":"1986","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.sder.2011.08.001_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0190-9622(91)70001-I","article-title":"Biology of basal cell carcinoma (part I)","volume":"24","author":"Miller","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1524-4725.2004.30083.x","article-title":"A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer","volume":"30","author":"Marmur","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2011.08.001_bib58","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2008.08882.x","article-title":"Guidelines for topical photodynamic therapy: Update","volume":"159","author":"Morton","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1046\/j.1365-2133.2002.04719.x","article-title":"Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group","volume":"146","author":"Morton","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib60","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O","article-title":"5-Aminolevulinic acid-based photodynamic therapy: Clinical research and future challenges","volume":"79","author":"Peng","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.sder.2011.08.001_bib61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2133.2000.03404.x","article-title":"Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique","volume":"142","author":"Thissen","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2133.2007.07996.x","article-title":"A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma","volume":"157","author":"Berroeta","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2001.04407.x","article-title":"A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage","volume":"145","author":"Soler","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2006.09.008","article-title":"Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma","volume":"25","author":"Szeimies","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.sder.2011.08.001_bib65","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1365-2133.2003.05600.x","article-title":"Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment","volume":"149","author":"Horn","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib66","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2133.2005.06484.x","article-title":"Photodynamic therapy with topical methyl aminolaevulinate for \u201cdifficult-to-treat\u201d basal cell carcinoma","volume":"152","author":"Vinciullo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib67","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: A 5 year randomized trial","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archderm.140.1.17","article-title":"Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: Results of a multicenter randomized prospective trial","volume":"140","author":"Rhodes","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib69","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib70","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.sder.2011.08.001_bib71","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaad.2004.01.027","article-title":"Cutaneous T-cell lymphoma","volume":"51","author":"Duvic","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1751-1097.1995.tb02356.x","article-title":"The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA)","volume":"61","author":"Rittenhouse-Diakun","year":"1995","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/000155501750376276","article-title":"Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: Clinical and histological response","volume":"81","author":"Edstr\u00f6m","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2011.08.001_bib74","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2230.2002.01119.x","article-title":"Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma","volume":"27","author":"Leman","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib75","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1524-4725.2000.00056.x","article-title":"Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application","volume":"26","author":"Orenstein","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2011.08.001_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0190-9622(03)00868-5","article-title":"Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma","volume":"50","author":"Coors","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0781.2006.00246.x","article-title":"Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma","volume":"22","author":"Zane","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.sder.2011.08.001_bib78","doi-asserted-by":"crossref","first-page":"896161","DOI":"10.1155\/2010\/896161","article-title":"Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and Sezary syndrome","volume":"2010","author":"Lam","year":"2010","journal-title":"Adv Hematol"},{"key":"10.1016\/j.sder.2011.08.001_bib79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib80","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JB.133.2.811-815.1978","article-title":"Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum","volume":"133","author":"Lee","year":"1978","journal-title":"J Bacteriol"},{"key":"10.1016\/j.sder.2011.08.001_bib81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2133.2005.06530.x","article-title":"Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III","volume":"153","author":"Schaller","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib82","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2340\/00015555-0088","article-title":"In vivo porphyrin production by P. acnes in untreated acne patients and its modulation by acne treatment","volume":"86","author":"Borelli","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2011.08.001_bib83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1574-695X.2003.tb00644.x","article-title":"Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light","volume":"35","author":"Ashkenazi","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.sder.2011.08.001_bib84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1751-1097.1986.tb05592.x","article-title":"An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization","volume":"43","author":"Kjeldstad","year":"1986","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib85","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0923-1811(02)00068-3","article-title":"Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: An open study and in vitro investigation","volume":"30","author":"Kawada","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.sder.2011.08.001_bib86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1523-1747.2000.00046.x","article-title":"Topical ALA-photodynamic therapy for the treatment of acne vulgaris","volume":"115","author":"Hongcharu","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib87","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2133.2004.06110.x","article-title":"Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: A study of clinical efficacy and mechanism of action","volume":"151","author":"Pollock","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib88","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2133.2001.04086.x","article-title":"Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients","volume":"144","author":"Itoh","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib89","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2133.2005.07107.x","article-title":"Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: A blinded, randomized, controlled trial","volume":"154","author":"Wiegell","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib90","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaad.2005.12.033","article-title":"Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate","volume":"54","author":"Wiegell","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib91","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1523-1747.ep12298282","article-title":"The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy","volume":"107","author":"Stringer","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib92","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/000155599750009898","article-title":"Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy","volume":"79","author":"Robinson","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2011.08.001_bib93","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1523-1747.2002.01827.x","article-title":"Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques","volume":"119","author":"Bissonnette","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib94","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2133.2004.06363.x","article-title":"Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis?","volume":"152","author":"Radakovic-Fijan","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib95","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1468-3083.2006.01651.x","article-title":"Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis: A randomized, double-blind phase I\/II study","volume":"20","author":"Schleyer","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.08.001_bib96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1346-8138.2007.00213.x","article-title":"Topical 5-aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasis","volume":"34","author":"Kim","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0022-3859.928","article-title":"Cutaneous leishmaniasis: An overview","volume":"49","author":"Hepburn","year":"2003","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.sder.2011.08.001_bib98","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/archderm.139.4.432","article-title":"Treatment of cutaneous leishmaniasis with photodynamic therapy","volume":"139","author":"Enk","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib99","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1610-0387.2007.06177.x","article-title":"Photodynamic treatment of cutaneous leishmaniasis","volume":"5","author":"Sohl","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.sder.2011.08.001_bib100","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1067\/mjd.2003.218","article-title":"Treatment of cutaneous leishmaniasis by photodynamic therapy","volume":"48","author":"Gardlo","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib101","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","article-title":"Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: A placebo-controlled, randomized clinical trial","volume":"31","author":"Asilian","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib102","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.1074\/jbc.M200107200","article-title":"Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy","volume":"277","author":"Sah","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sder.2011.08.001_bib103","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.jid.5700719","article-title":"A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis","volume":"127","author":"Kosaka","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib104","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1529-8019.2010.01350.x","article-title":"An overview of human papillomavirus infection for the dermatologist: Disease, diagnosis, management, and prevention","volume":"23","author":"Forcier","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2011.08.001_bib105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0002-9378(96)70332-0","article-title":"Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid","volume":"174","author":"Fehr","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.sder.2011.08.001_bib106","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2133.1997.tb01110.x","article-title":"Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: Implications for photodynamic treatment","volume":"137","author":"Ross","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib107","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2230.1999.00441.x","article-title":"Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: A pilot study","volume":"24","author":"Stender","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib108","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(00)90013-8","article-title":"Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: Randomised double-blind trial","volume":"355","author":"Stender","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.08.001_bib109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1011-1344(01)00141-5","article-title":"Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts","volume":"61","author":"Fabbrocini","year":"2001","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.sder.2011.08.001_bib110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0781.2009.00439.x","article-title":"Dramatic clearance of a recalcitrant acral viral wart using methyl aminolevulinate-red light photodynamic therapy","volume":"25","author":"Chong","year":"2009","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.sder.2011.08.001_bib111","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1524-4725.2009.01307.x","article-title":"Enhanced efficacy of photodynamic therapy with methyl 5-aminolevulinic acid in recalcitrant periungual warts after ablative carbon dioxide fractional laser: A pilot study","volume":"35","author":"Yoo","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.sder.2011.08.001_bib112","first-page":"70","article-title":"Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid","volume":"72","author":"Frank","year":"1996","journal-title":"Genitourin Med"},{"key":"10.1016\/j.sder.2011.08.001_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2230.2005.01935.x","article-title":"Photodynamic therapy of genital condylomata in men","volume":"31","author":"Herzinger","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib114","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/lsm.10048","article-title":"Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid","volume":"30","author":"Fehr","year":"2002","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.sder.2011.08.001_bib115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2133.2006.07648.x","article-title":"Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: A randomized clinical trial","volume":"156","author":"Chen","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.08.001_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micres.2007.08.001","article-title":"Antifungal photodynamic therapy","volume":"163","author":"Donnelly","year":"2008","journal-title":"Microbiol Res"},{"key":"10.1016\/j.sder.2011.08.001_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0195-6701(03)00085-9","article-title":"Management and outcome of bloodstream infections due to Candida species in England and Wales","volume":"54","author":"Kibbler","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.sder.2011.08.001_bib118","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(95)91314-9","article-title":"Can we prevent azole resistance in fungi?","volume":"346","author":"Denning","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.08.001_bib119","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1562\/0031-8655(2003)077<0556:PIOTDT>2.0.CO;2","article-title":"Photodynamic inactivation of the dermatophyte Trichophyton rubrum","volume":"77","author":"Smijs","year":"2003","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib120","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1751-1097.2011.00938.x","article-title":"Photodynamic Therapy with Pc 4 Induces Apoptosis of Candida albicans","volume":"87","author":"Lam","year":"2011","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.sder.2011.08.001_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2004.06.006","article-title":"A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin","volume":"78","author":"Calzavara-Pinton","year":"2005","journal-title":"J Photochem Photobiol B Biol"},{"key":"10.1016\/j.sder.2011.08.001_bib122","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1468-3083.2008.02880.x","article-title":"5-Aminolevulininic acid photodynamic therapy treatment for tinea cruris caused by Trichophyton rubrum: Report of 10 cases","volume":"23","author":"Sotiriou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.08.001_bib123","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1468-3083.2008.02783.x","article-title":"5-Aminolevulinic acid-photodynamic treatment for dermatophytic tinea pedis of interdigital type: A small clinical study","volume":"23","author":"Sotiriou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.08.001_bib124","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1600-0781.2004.00095.x","article-title":"Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid","volume":"20","author":"Calzavara-Pinton","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.sder.2011.08.001_bib125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2340\/00015555-0811","article-title":"Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial","volume":"90","author":"Sotiriou","year":"2010","journal-title":"Acta Derm Venereol"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/Vol30_i4-Lee.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T07:37:14Z","timestamp":1713166634000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1085562911001258"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2011.08.001","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}